Davids Perlin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
CDI Director Perlin Named to Modern Healthcare s Class of Top 25 Innovators
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
CDI s Perlin Named a Top 25 Innovator by Modern Healthcare - New Jersey Business Magazine
njbmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbmagazine.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: The Hackensack Meridian Health scientists and clinicians continue to study the promise and potential of convalescent plasma for COVID-19 treatment. view more
Credit: Hackensack Meridian Health
March 10, 2021 - Hackensack, NJ - Convalescent plasma, the use of survivors antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels of antibodies, according to a new publication by scientists at Hackensack Meridian Health, New Jersey s largest and most comprehensive health network.
The treatment was safe, transferred the survivors antibodies, and did not prevent the recipients from making their own antibodies, according to the results published recently in the journal
Share this article
Share this article
HACKENSACK, N.J., March 10, 2021 /PRNewswire/ Convalescent plasma, the use of survivors antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels of antibodies, according to a new publication by scientists at Hackensack Meridian
Health, New Jersey s largest and most comprehensive health network.
The treatment was safe, transferred the survivors antibodies, and did not prevent the recipients from making their own antibodies, according to the results published recently in the journal We have developed this technique and methodology to save the lives of patients, said Michele Donato, M.D., FACP, CPE, chief of Stem Cell Transplantation and Cellular Therapy at John Theurer Cancer Center at Hackensack University Medical Center, and who is leading the study. We believe our hard work is paying off.